BEAM Long Put Strategy
BEAM (Beam Therapeutics Inc.), in the Healthcare sector, (Biotechnology industry), listed on NASDAQ.
Beam Therapeutics Inc., founded in 2017 and based in Cambridge, Massachusetts, operates as a pioneering biopharmaceutical firm. Its core mission involves engineering precise genetic remedies to tackle a spectrum of severe human ailments, primarily within the United States. The company's developmental portfolio features several key candidates: BEAM-101 is being advanced to treat both sickle cell disease and beta thalassemia. BEAM-102 is specifically designed for addressing sickle cell disease. BEAM-201, an allogeneic chimeric antigen receptor T-cell therapy, is under investigation for individuals suffering from relapsed or refractory T-cell acute lymphoblastic leukemia. BEAM-301 is a liver-targeted candidate aimed at patients afflicted with Glycogen Storage Disease Type Ia.
BEAM (Beam Therapeutics Inc.) trades in the Healthcare sector, specifically Biotechnology, with a market capitalization of approximately $3.58B, a beta of 2.20 versus the broader market, a 52-week range of 15.6-36.88, average daily share volume of 2.1M, a public-listing history dating back to 2020, approximately 393 full-time employees. These structural characteristics shape how BEAM stock options price implied volatility around earnings windows, capital events, and macro-driven sector rotations.
A beta of 2.20 indicates BEAM has historically moved more than the broader market, amplifying both the directional payoff and the realized volatility relative to an index-equivalent position.
What is a long put on BEAM?
A long put buys downside exposure with a fixed maximum loss equal to the premium paid; profit accrues if the underlying closes below the strike minus premium at expiration.
Current BEAM snapshot
As of June 30, 2026, spot at $34.75, ATM IV 80.00%, IV rank 39.90%, expected move 22.94%. The long put on BEAM below is built from the same end-of-day chain, with strikes snapped to listed contracts and premiums pulled from the bid/ask midpoint at a 17-day expiry.
Why this long put structure on BEAM specifically: BEAM IV at 80.00% is mid-range versus its 1-year history, so strategy selection should anchor more to the directional thesis than to the IV regime, with a market-implied 1-standard-deviation move of approximately 22.94% (roughly $7.97 on the underlying). The 17-day window matched to the front-month expiry keeps theta exposure bounded while still capturing the post-snapshot move; longer-dated BEAM expiries trade a higher absolute premium for lower per-day decay. Position sizing on BEAM should anchor to the underlying notional of $34.75 per share and to the trader's directional view on BEAM stock.
BEAM long put setup
The BEAM long put below is built from the end-of-day chain, with each option leg priced at the bid/ask midpoint of its listed strike. With BEAM near $34.75, the first option leg uses a $35.00 strike; additional legs (when the strategy has them) anchor to spot-relative offsets. Premiums come from the bid/ask midpoint on the listed BEAM chain at a 17-day expiry; the cross-strike IV skew is reflected directly in the per-leg values rather than approximated. Quantity sizing assumes one contract per option leg (or 100 BEAM shares for the stock leg in covered calls and collars).
| Action | Type | Strike / Basis | Premium (est) |
|---|---|---|---|
| Buy 1 | Put | $35.00 | $2.40 |
BEAM long put risk and reward
- Net Premium / Debit
- -$240.00
- Max Profit (per contract)
- $3,259.00
- Max Loss (per contract)
- -$240.00
- Breakeven(s)
- $32.60
- Risk / Reward Ratio
- 13.579
Max profit equals the strike minus premium times 100 (reached at zero); max loss equals the premium times 100. Breakeven is strike minus premium.
BEAM long put payoff curve
Modeled P&L at expiration across a range of underlying prices for the long put on BEAM. Each row is one sampled price point from the computed payoff curve; the full curve uses 200 price points internally before being summarized into 10 rows here.
| Underlying Price | % From Spot | P&L at Expiration |
|---|---|---|
| $0.01 | -100.0% | +$3,259.00 |
| $7.69 | -77.9% | +$2,490.77 |
| $15.37 | -55.8% | +$1,722.54 |
| $23.06 | -33.6% | +$954.31 |
| $30.74 | -11.5% | +$186.08 |
| $38.42 | +10.6% | -$240.00 |
| $46.10 | +32.7% | -$240.00 |
| $53.79 | +54.8% | -$240.00 |
| $61.47 | +76.9% | -$240.00 |
| $69.15 | +99.0% | -$240.00 |
When traders use long put on BEAM
Long puts on BEAM hedge an existing long BEAM stock position or express a bearish view with defined risk; position sizing typically scales the put notional to the underlying BEAM exposure being hedged.
BEAM thesis for this long put
The market-implied 1-standard-deviation range for BEAM extends from approximately $26.78 on the downside to $42.72 on the upside. A BEAM long put expresses a directional view that the underlying closes below the strike minus premium at expiration, frequently sized to hedge an existing long BEAM position with one put per 100 shares held. Current BEAM IV rank near 39.90% is mid-range against its 1-year distribution, so the IV signal is neutral; the long put thesis on BEAM should anchor more to the directional view and the expected-move geometry. As a Healthcare name, BEAM options can move on sector-level news flow (peer earnings, regulatory updates, industry-specific macro data) in addition to BEAM-specific events.
BEAM long put positions are structurally bearish; the modeled P&L assumes European-style exercise at expiration and ignores early assignment, transaction costs, dividends paid before expiry on the stock leg (when present), and the bid-ask spread on the listed chain. BEAM positions also carry Healthcare sector concentration risk; news flow inside the sector (peer earnings, regulatory shifts, supply-chain headlines) can move BEAM alongside the broader basket even when BEAM-specific fundamentals are unchanged. Long-premium structures like a long put on BEAM are particularly exposed to IV-crush risk through scheduled events (earnings, FDA decisions, central-bank meetings) where IV typically contracts post-event regardless of the directional outcome. Always rebuild the position from current BEAM chain quotes before placing a trade.
Frequently asked questions
- What is a long put on BEAM?
- A long put on BEAM is the long put strategy applied to BEAM (stock). The strategy is structurally bearish: A long put buys downside exposure with a fixed maximum loss equal to the premium paid; profit accrues if the underlying closes below the strike minus premium at expiration. With BEAM stock trading near $34.75, the strikes shown on this page are snapped to the nearest listed BEAM chain strike and the premiums come straight from the end-of-day bid/ask midpoint.
- How are BEAM long put max profit and max loss calculated?
- Max profit equals the strike minus premium times 100 (reached at zero); max loss equals the premium times 100. Breakeven is strike minus premium. For the BEAM long put priced from the end-of-day chain at a 30-day expiry (ATM IV 80.00%), the computed maximum profit is $3,259.00 per contract and the computed maximum loss is -$240.00 per contract. Live intraday quotes will differ as the chain moves through the trading session.
- What is the breakeven for a BEAM long put?
- The breakeven for the BEAM long put priced on this page is roughly $32.60 at expiration, derived from end-of-day chain premiums. Breakeven is the underlying price at which the strategy's P&L crosses zero ignoring transaction costs and assignment risk. The current BEAM market-implied 1-standard-deviation expected move is approximately 22.94%; if the move sits well outside the breakeven distance, the structure's risk-reward becomes correspondingly tighter.
- When should you consider a long put on BEAM?
- Long puts on BEAM hedge an existing long BEAM stock position or express a bearish view with defined risk; position sizing typically scales the put notional to the underlying BEAM exposure being hedged.
- How does current BEAM implied volatility affect this long put?
- BEAM ATM IV is at 80.00% with IV rank near 39.90%, which is mid-range against its 1-year history. Strategy selection depends more on directional thesis and expected move than on a strong IV signal.